CABARLES, AVE GAIL C. MR. MARK JAMES B.

ORTEGA

BS CRIMINOLOGY- 1ST YEAR SECTION 2463 PURPOSIVE COMMUNICATION

“COVID-19 VACCINES”
(WRITTEN REPORT)

Coronavirus disease (COVID-19) is a newly found coronavirus that causes an infectious

disease. The majority of patients infected with the COVID-19 virus will have mild to moderate
respiratory symptoms and will recover without needing any specific therapy. People over the age of
65, as well as those with underlying medical conditions such as cardiovascular disease, diabetes,
chronic respiratory disease, and cancer, are at a higher risk of developing serious illness.

Safe and efficient vaccines are a game-changing tool, but we must continue to wear masks,
wash our hands, ensure proper ventilation indoors, and physically distance ourselves from crowds for
the foreseeable future. It’s crucial to have equitable access to safe and effective vaccines if the
COVID-19 pandemic is to be stopped, so seeing so many vaccines being tested and developed is quite
encouraging. WHO and its partners are working relentlessly to discover, manufacture, and distribute
safe and effective vaccinations. Only vaccine efficacy (VE) data is currently available, as
“effectiveness” is dependent on a variety of conditions and requires a longer observation time.
AstraZeneca COVID-19 Vaccine (ChAdOx1-S [recombinant]): overall VE against symptomatic
COVID-19 was 70.4 percent (95 percent CI 54.8 to 80.6 percent) 14 days following the second dose.
Sinovac CoronaVac: 65 to 91% (based on Brazil, Indonesia and Turkey Trials).Janssen: 66.9% (95%
CI 59.0 to 73.4%) against confirmed moderate to severe/critical COVID-19, 14 days after
vaccination; 66.1% (95% CI 55.0 to 74.8%) against confirmed moderate to severe/critical COVID-19,
28 days after vaccination; ~77% effective in preventing severe/critical COVID-19 occurring at least
14 days after vaccination and 85% effective in preventing severe/critical COVID-19 occurring at least
28 days after vaccination.

"The long days and nights of waiting are finally over. These vaccines will be of great help to
our valiant healthcare workers who have been at the forefront of the battle against the COVID-19
pandemic. With every dose that we will administer, we are inching towards a safer recovery from this
pandemic. So, let us put our trust in science, in vaccines. Together, we will rise as a nation and heal as
one,” says Department of Health Secretary Francisco T. Duque III. Being vaccinated does not exempt
us from exercising caution and putting ourselves and others at risk, especially because research into
the extent to which vaccines protect not only against disease but also against infection and
transmission is still underway.